By Catharine Paddock
U.S. scientists researching treatments for sinus infections suggest that antibiotics are overprescribed to treat the condition. And they are concerned this could be increasing the drug resistance and virulence of infectious bacteria. The study was published in the March issue of Archives of Otolaryngology-Head & Neck Surgery.
According to the study, by Hadley J. Sharp and colleagues at the University of Nebraska Medical Center, Omaha, US, antibiotics were prescribed for 82 per cent of acute sinus infections and nearly 70 per cent of chronic sinus infections.
This is surprising because most sinus infections are caused by viruses, and antibiotics only kill bacteria.
The scientists used national data from 1999 and 2002 to find out which drugs were being prescribed for sinus infections by general practitioners, outpatient and emergency departments. The data was representative of the U.S. population and came from two national surveys collected by the NationalCenter for Health Statistics.
Rhinosinusitis, commonly known as sinus infection or sinusitis, is an inflammation of the sinus cavities that connect with the nasal passage. According to the study, it is a common and expensive medical condition in the U.S.
Acute sinusitis occurs for up to four weeks and is thought to be caused mostly by infectious agents. Chronic sinusitis is thought to be affected mostly by allergies, hormone changes and facial anatomy and symptoms persist for 12 or more weeks.
In 2002, of all the antibiotic prescriptions that year in the U.S., 21 percent were for adults with sinus infections and 9 percent was for children.
According to the survey data, more than 14 million visits are paid to healthcare facilities in the U.S. every year are for chronic sinusitis, while more than 3 million are for acute sinusitis. As a proportion of all ambulatory care in the U.S. per year, chronic sinusitis represents 1.39 percent of visits and acute sinusitis 0.30 percent.
In 69.95 percent of visits for chronic sinusitis at least one antibiotic was prescribed. For acute sinusitis this figure was 82.74 percent.
Sharp and colleagues report, "The most frequently recommended medications for treatment of both acute and chronic rhinosinusitis are antibiotic agents, followed by antihistamines; nasal decongestants; corticosteroids; and antitussive, expectorant and mucolytic agents, respectively."
The most commonly used antibiotics for both chronic and acute bacterial infections were penicillins (mainly amoxicillin and amoxicillin-clavulanate potassium, brand name Augmentin). These were prescribed appropriately, they said, with 30.35 percent of chronic and 27.18 percent of acute infection visits mentioning penicillin prescriptions.
However, the researchers questioned the use of the stronger antibiotics such as erythromycins, lincosamides, and macrolides, amongst others. These were mentioned in 24.32 percent of acute sinusitis visits, which, in order, makes them more frequently prescribed than cephalosporins, sulfonamides and trimethprim, and tetracyclines.
The authors assessed the relative proportions of the causes of sinusitis from other studies. Comparing these proportions with the relative proportions of what is actually being prescribed to treat sinusitis they found major discrepancies.
They concluded that, "Prescription antibiotic drugs are being used far more than bacterial causes studies would indicate."
Sharp and colleagues also assessed that, "Nasal and inhaled corticosteroids are prescribed more frequently to treat acute rhinosinusitis than published studies imply is necessary. However, they estimated that where antihistamines were prescribed, this was roughly in proportion with estimated prevalence of allergic sinusitis.
In trying to fathom why the use of antibiotics is so high, the authors suggest that some doctors could be trying to treat secondary infections. On the other hand, it could be because doctors think antibiotics are working because patients get better while taking them, whereas they could be getting better anyway.
They express concern about the problems that overuse of antibiotics bring, including drug resistance and increased virulence of bacteria. They conclude, "When two-thirds of patients with sinus symptoms expect or receive an antibiotic and as many as one-fifth of antibiotic prescriptions for adults are written for a drug to treat rhinosinusitis, these disorders hold special pertinence on the topic."
Reference: Sharp HJ, Denman D, Puumala S, and Leopold DA. Treatment of acute and chronic rhinosinusitis in the United States, 1999-2002. Arch Otolaryngol Head Neck Surg. 2007;133:260-265. Vol. 133 No. 3, March 2007.
Source: Medical News Today
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.